GIP and GLP-2 together improve bone turnover in humans supporting GIPR-GLP-2R co-agonists as future osteoporosis treatment
M Gabe, Kirsa Skov‐Jeppesen, Lærke S. Gasbjerg, Sine Pasch Schiellerup, Christoffer Martinussen, Sarina Gadgaard, Geke Aline Boer, Jannika Oeke, Lola Torz, Simon Veedfald, Maria S. Svane, Kirstine N. Bojsen‐Møller, Sten Madsbad, Jens J. Holst, Bolette Hartmann, Mette M. Rosenkilde
Topics & Concepts
EndocrinologyInternal medicineReceptorBone remodelingPostprandialBone resorptionGlucagon-like peptide-1OsteoporosisHormoneGastric inhibitory polypeptideMedicineChemistryPharmacologyGlucagonType 2 diabetesDiabetes mellitusDiabetes Treatment and ManagementNeuropeptides and Animal PhysiologyMetabolism, Diabetes, and Cancer